Stress by restraining potentiates morphine catalepsy in rats

Area of Science:

• Neuropharmacology
• Behavioral Neuroscience

Background:

• Stress can significantly alter the effects of drugs.
• Morphine-induced catalepsy is a well-established model for studying opioid and central nervous system (CNS) activity.

Purpose of the Study:

• To investigate the influence of restraint stress on morphine catalepsy in rats.
• To explore the neurochemical mechanisms underlying stress-induced potentiation of morphine catalepsy.

Main Methods:

• Rats were subjected to restraint stress.
• Morphine catalepsy was induced and measured.
• Pharmacological agents targeting serotonin, acetylcholine, prostaglandins, and dopamine systems were administered.
• Naloxone was used to assess opioid receptor involvement.

Main Results:

• Restraint stress significantly potentiated morphine catalepsy.
• Treatments that decreased central serotonin, acetylcholine, or prostaglandins partially antagonized this potentiation.
• A selective increase in central dopamine also inhibited the stress-induced potentiation of catalepsy.
• Naloxone partially antagonized the potentiation, suggesting some opioid receptor involvement.

Conclusions:

• Restraint stress exacerbates morphine-induced catalepsy in rats.
• Serotonin, acetylcholine, and prostaglandin systems play a role in mediating this stress-induced potentiation.
• Dopamineergic pathways may counteract the effects of stress on morphine catalepsy.
• These findings highlight the complex interplay between stress and opioid pharmacodynamics.